Xtx Topco LTD Eiger Bio Pharmaceuticals, Inc. Transaction History

Xtx Topco LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$0.28 - $0.93 $11,389 - $37,827	-40,675 Reduced 72.28%	15,597 $4,000
Q2 2023 Aug 14, 2023	SELL	$0.55 - $1.26 $80,843 - $185,204	-146,988 Reduced 72.32%	56,272 $39,000
Q1 2023 May 12, 2023	SELL	$0.89 - $2.52 $75,706 - $214,361	-85,064 Reduced 29.5%	203,260 $182,000
Q4 2022 Feb 14, 2023	BUY	$1.02 - $7.48 $294,090 - $2.16 Million	288,324 New	288,324 $340,000
Q2 2022 Aug 15, 2022	BUY	$4.99 - $8.96 $193,127 - $346,778	38,703 New	38,703 $244,000

748K

Ticker EIGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,966,800
Market Cap $490M
Description
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.